Fresh analysis reveals that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop traditional lifestyle programs.
Published data in a leading health publication shows that while overweight people frequently drop substantial amounts of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month once they quit.
"Individuals using such medications must be informed of the danger of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.
That rate of regain implies a return to starting weight in about 18 months.
Weighing Treatments
The research, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists emphasize that individuals who lose weight through diet and exercise generally see a slower weight regain—around 100 grams monthly—post-intervention.
The Reason for the Rapid Regain
Experts suggest the way of the injections explains the amplified rebound.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating far more likely."
A Lifelong Issue?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, due to the high risk of relapse, the treatment is often life-long.
This perspective is supported by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," comparing it to managing diseases like diabetes.
User Experiences
Individuals who have discontinued the medication describe a sudden resurgence of appetite.
"It felt as if something that goes on and I was suddenly ravenous," recalled a patient.
This difficulty is worsened if patients have not developed permanent lifestyle or habit modifications during therapy.
Growing Adoption
Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is more common among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Finally, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a permanent solution and long-term success relies on ongoing lifestyle management.
